- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Kilitch Drugs (India) Ltd has announced a board meeting to discuss the financial results for the quarter and half-year ended December 31, 2024. The company reported total income from operations of ₹ 12.49 crore, up from ₹ 8.47 crore year-over-year. Net profit after tax was ₹ 1.43 crore compared to ₹ 0.68 crore in the previous year. This positive trend reflects the company's operational strength and could enhance investor confidence, indicative of a positive outlook moving forward despite industry challenges. Continued monitoring of future performance is advisable to gauge sustainability.